Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.9 |
mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.9 |
mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.9 |
mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.9 |
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |